TY  - JOUR
AU  - Carmona Martinez, Alfonso
AU  - Prymula, Roman
AU  - Miranda Valdivieso, Mariano
AU  - Otero Reigada, Maria Del Carmen
AU  - Merino Arribas, Jose Manuel
AU  - Brzostek, Jerzy
AU  - Szenborn, Leszek
AU  - Ruzkova, Renata
AU  - Horn, Michael R
AU  - Jackowska, Teresa
AU  - Centeno-Malfaz, Fernando
AU  - Traskine, Magali
AU  - Dobbelaere, Kurt
AU  - Borys, Dorota
PY  - 2018
DO  - 10.1016/j.vaccine.2018.07.023
UR  - http://hdl.handle.net/10668/12767
T2  - Vaccine
AB  - We assessed 2 investigational 11- and 12-valent vaccines, containing capsular polysaccharides of 10 serotypes as in the pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) and CRM197-conjugated capsular...
LA  - en
KW  - Immunogenicity
KW  - Infants/children
KW  - Non-inferiority
KW  - PHiD-CV
KW  - Pneumococcal conjugate vaccine
KW  - Safety
KW  - Antibodies, Bacterial
KW  - Bacterial Proteins
KW  - Carrier Proteins
KW  - Diphtheria-Tetanus-Pertussis Vaccine
KW  - Female
KW  - Haemophilus influenzae
KW  - Hepatitis B Vaccines
KW  - Humans
KW  - Immunization, Secondary
KW  - Immunogenicity, Vaccine
KW  - Immunoglobulin D
KW  - Infant
KW  - Lipoproteins
KW  - Male
KW  - Pneumococcal Infections
KW  - Pneumococcal Vaccines
KW  - Poliovirus Vaccine, Inactivated
KW  - Serogroup
KW  - Streptococcus pneumoniae
KW  - Vaccines, Combined
KW  - Vaccines, Conjugate
TI  - Immunogenicity and safety of 11- and 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccines (11vPHiD-CV, 12vPHiD-CV) in infants: Results from a phase II, randomised, multicentre study.
TY  - research article
VL  - 37
ER  -